Skip to main content

9 Result(s)

within Daniela Di Lisi Remove this filter

and

  1. Article

    Open Access

    Right ventricle involvement in patients with breast cancer treated with chemotherapy

    Anthracyclines can cause left ventricular (LV) dysfunction. There is little data about right ventricular (RV) damage during chemotherapy.

    Ludovico Rossetto, Daniela Di Lisi, Cristina Madaudo… in Cardio-Oncology (2024)

    Download PDF (1579 KB) View Article

  2. No Access

    Article

    Chemotherapy-related cardiac dysfunction: the usefulness of myocardial work indices

    Aims: The role of left ventricular global longitudinal strain (GLS) in the diagnosis of subclinical cardiac damage induced by anticancer drugs is now consolidated. Considering some strain disadvantages such as...

    Daniela Di Lisi, Girolamo Manno… in The International Journal of Cardiovascula… (2023)

  3. No Access

    Article

    Effects of SGLT2 inhibitors on cardiac structure and function

    SGLT2 inhibitors reduce cardiovascular death or hospitalization for heart failure, regardless of the presence or absence of diabetes in patients at high cardiovascular risk and in those with heart failure and ...

    Giuseppina Novo, Tommaso Guarino, Daniela Di Lisi, Paolo Biagioli… in Heart Failure Reviews (2023)

  4. No Access

    Chapter

    Diagnostic Methods of Cardiac Immunotherapy Damaging

    Immune checkpoint inhibitors (ICIs) in the last few years are becoming a mainstay of cancer treatment. Although adverse events from immune ICIs are a common occurrence, cardiotoxic (CTX) effects are uncommon, ...

    Girolamo Manno, Daniela Di Lisi, Giuseppina Novo in Cardio-Oncology (2022)

  5. No Access

    Article

    The prognostic role of CMR using global planimetric criteria in patients with excessive left ventricular trabeculation

    Although cardiovascular magnetic resonance (CMR) is widely used in the assessment of left ventricular non-compaction (LVNC), there are no universally accepted diagnostic criteria and limited data regarding the...

    Francesca Macaione, Antonella Meloni, Vincenzo Positano… in European Radiology (2021)

  6. No Access

    Chapter

    Cardiovascular Damage Induced by Anti-VEGF Therapy

    Vascular endothelial growth factor (VEGF) plays an important role in maintaining the regular homeostasis of vascular walls. VEGF binds its receptor (VEGFR) promoting the regular survival and function of endoth...

    Giuseppina Novo, Daniela Di Lisi… in Cardiovascular Complications in Cancer The… (2019)

  7. No Access

    Chapter

    Cardiovascular Damage Induced by Anti-BCR-ABL TKIs

    Anti-BCR-ABL TKIs (tyrosine kinase inhibitors) are drugs that inhibit BCR ABL tyrosine. They are used especially in the treatment of hematological cancer and gastrointestinal stromal tumors (GIST). Anti-BCR-AB...

    Giuseppina Novo, Daniela Di Lisi… in Cardiovascular Complications in Cancer The… (2019)

  8. Article

    Open Access

    Preclinical atherosclerosis and metabolic syndrome increase cardio- and cerebrovascular events rate: a 20-year follow up

    Intima-media thickness (IMT) is a validated marker of preclinical atherosclerosis and a predictor of cardiovascular events.

    Salvatore Novo, Angelica Peritore, Rosaria Linda Trovato… in Cardiovascular Diabetology (2013)

    Download PDF (528 KB) View Article

  9. No Access

    Article

    Timely Recognition of Cardiovascular Toxicity by Anticancer Agents: A Common Objective of the Pharmacologist, Oncologist and Cardiologist

    Both conventional and new anticancer drugs can frequently cause adverse cardiovascular effects, which can span from subclinical abnormalities to serious life-threatening and sometimes fatal events. This review...

    Francesca Bonura, Daniela Di Lisi, Salvatore Novo… in Cardiovascular Toxicology (2012)